Tobias Herold

About Tobias Herold

Tobias Herold, With an exceptional h-index of 39 and a recent h-index of 35 (since 2020), a distinguished researcher at Ludwig-Maximilians-Universität München, specializes in the field of Hematology and Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Friday Leukemia—a Structural Phenomenon

Prognostic impact of CEBPA mutational subgroups in adult AML

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)

Identification of a gene expression signature associated with brain metastasis in colorectal cancer

Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome

Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?

Tobias Herold Information

University

Position

Attending physician and research group leader

Citations(all)

7012

Citations(since 2020)

5621

Cited By

3389

hIndex(all)

39

hIndex(since 2020)

35

i10Index(all)

75

i10Index(since 2020)

71

Email

University Profile Page

Google Scholar

Tobias Herold Skills & Research Interests

Hematology and Oncology

Top articles of Tobias Herold

Friday Leukemia—a Structural Phenomenon

Deutsches Ärzteblatt International

2024/2

Stephanie Schneider
Stephanie Schneider

H-Index: 1

Tobias Herold
Tobias Herold

H-Index: 29

Prognostic impact of CEBPA mutational subgroups in adult AML

Leukemia

2024/1/16

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)

Leukemia

2024/1

Identification of a gene expression signature associated with brain metastasis in colorectal cancer

Laboratory Investigation

2018/3/1

Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

Nature biotechnology

2023/11

CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition

HemaSphere

2023/10/1

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome

British Journal of Haematology

2023/9

Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?

Blood Advances

2023/8/8

Tobias Herold
Tobias Herold

H-Index: 29

P446: COMPREHENSIVE CHARACTERIZATION OF DIFFERENTIAL GENE EXPRESSION AND ISOFORM USAGE IN SPLICING FACTOR-MUTATED ACUTE MYELOID LEUKEMIA USING LONG-READ SEQUENCING

HemaSphere

2023/8/1

DDX41-Low Expression Mimics Germline DDX41-Phenotype in Acute Myeloid Leukemia

Blood

2023/12/1

P457: COMPLEX CARYOTYPE IS AN INDEPENDENT RISK FACTOR IN TP53-MUTATED AML

HemaSphere

2023/8/1

Stephanie Schneider
Stephanie Schneider

H-Index: 1

Tobias Herold
Tobias Herold

H-Index: 29

P434: MYELODYSPLASIA-RELATED MUTATIONS IN THE NEW ELN CLASSIFICATION: DOES CLONAL SIZE PLAY A ROLE?

HemaSphere

2023/8/1

Stephanie Schneider
Stephanie Schneider

H-Index: 1

Tobias Herold
Tobias Herold

H-Index: 29

Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo

Molecular Cancer

2023/7/8

Martin Becker
Martin Becker

H-Index: 7

Tobias Herold
Tobias Herold

H-Index: 29

Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

Leukemia

2023/6

Stephanie Schneider
Stephanie Schneider

H-Index: 1

Tobias Herold
Tobias Herold

H-Index: 29

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

Communications Medicine

2023/5/17

The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

American journal of hematology

2023/12

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board

2023/5

Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies

Blood

2023/11/28

Update Akute Myeloische Leukämie: Zahlreiche kleine und große Veränderungen in den letzten Jahren

DMW-Deutsche Medizinische Wochenschrift

2023/4

Tobias Herold
Tobias Herold

H-Index: 29

Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML

Blood advances

2023/3/28

See List of Professors in Tobias Herold University(Ludwig-Maximilians-Universität München)

Co-Authors

academic-engine